Event | March 5, 2025
Join us at AACR 2026
Get the Resource
Schedule an On-Site MeetingApril 19-22, 2026 | San Diego Convention Center | Booth 1412
Visit Sapient at this year’s AACR for a firsthand look into our latest service offering innovations and how they are reshaping modern cancer therapeutic development – helping teams advance programs with greater clarity, confidence, and success.
Whether you need deeper insight into functional tumor biology, faster biomarker validation, or real‑world confirmation of your findings, Sapient offers end‑to‑end, next‑generation proteomics and multi‑omics solutions built for today’s oncology R&D.
What We're Featuring at AACR
Next-Generation FFPE Proteomics
See how our innovative approach quantifies 10,000+ proteins, including phospho‑ and glyco‑proteins, isoforms, and PTMs, in FFPE tissue – unlocking functional biology insights that genomics and IHC cannot provide. We’ll show you the ways our workflow will enable you to:
- Bridge the gap from inferred to actual biology
- Action your existing FFPE archives
- Build confidence with mechanistic evidence
Tumor Protein Mapping Platform
Explore how our new platform profiles the most critical dimensions of tumor biology for oncology drug development, integrating multiple specialized enrichment workflows within our discovery proteomics offering, including:
- SurfaceSeek™: to identify drug-targetable tumor cell surface proteins
- OncoSeek™: to map oncogenic signaling & pathway activation
- ImmuneSeek™: to quantify dynamic immune states at the protein level
- ResistanceSeek™: to uncover adaptive tumor biology and resistance states
DynamiQ™ as a Differentiator for Oncology Programs
As the only multi-omics partner with a population-scale clinical-molecular database (DynamiQ), we offer a unique advantage to both analyze samples and validate the findings in independent real-world cohorts – as well as to uncover novel biology. See how we can help you:
- Confirm preclinical findings in patient populations
- Build a foundation model to map cancer phenotypes
- Enable virtual biomarker discovery
Visit Us at Booth 1412
Stop by our space in the Exhibit Hall to hear more about these offerings and to meet with our attending delegates, including Sherr Aquino, VP of Business Development, KJ Banuk, VP of Business Development and Partnerships, Ben Gonzales, VP of Commercial, and other key members of our team.
Schedule an On-Site Meeting
Have specific questions or programs you’d like to discuss? We would love to talk through your needs and how we can partner to accelerate your drug discovery and development efforts. Set up a 1-on-1 meeting during AACR 2026.